Abstract |
The notorious resistance of melanoma cells to drug treatment can be overcome by expression of a 50-aa peptide derived from activating transcription factor 2 (ATF2(50-100)). Here we demonstrate that ATF2(50-100) induced apoptosis by sequestering ATF2 to the cytoplasm, thereby inhibiting its transcriptional activities. Furthermore, ATF2(50-100) binds to c-Jun N-terminal kinase (JNK) and increases its activity. Mutation within ATF2(50-100) that impairs association with JNK and the inhibition of JNK or c-Jun expression by RNA interference (RNAi) reduces the degree of ATF2(50-100)-induced apoptosis. In contrast, TAM67, a dominant negative of the Jun family of transcription factors, or JunD RNAi attenuates sensitization of melanoma cells expressing ATF2(50-100) to apoptosis after treatment with anisomycin, which is used as a model drug. Mutations within the JNK binding region of ATF2(50-100) or expression of TAM67 or JunD RNAi attenuates inhibition of melanoma's tumorigenicity by ATF2(50-100). We conclude that inhibition of ATF2 in concert with increased JNK/Jun and JunD activities is central for the sensitization of melanoma cells to apoptosis and inhibition of their tumorigenicity.
|
Authors | Anindita Bhoumik, Nic Jones, Ze'ev Ronai |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 101
Issue 12
Pg. 4222-7
(Mar 23 2004)
ISSN: 0027-8424 [Print] United States |
PMID | 15010535
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- ATF2 protein, human
- Activating Transcription Factor 2
- Atf2 protein, mouse
- Cyclic AMP Response Element-Binding Protein
- Peptides
- Proto-Oncogene Proteins c-jun
- Transcription Factors
- JNK Mitogen-Activated Protein Kinases
- Mitogen-Activated Protein Kinases
|
Topics |
- Activating Transcription Factor 2
- Animals
- Apoptosis
(physiology)
- Cyclic AMP Response Element-Binding Protein
(metabolism)
- Cytoplasm
(metabolism)
- Humans
- JNK Mitogen-Activated Protein Kinases
- Melanoma
(metabolism)
- Mice
- Mitogen-Activated Protein Kinases
(genetics, metabolism)
- Mutation
- Peptides
(metabolism)
- Proto-Oncogene Proteins c-jun
(metabolism)
- Transcription Factors
(metabolism)
|